NA
THC icon

NewEdge Advisors’s Tenet Healthcare THC Stock Holding History

NewEdge Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$955K Sell
5,106
-1,074
-17% -$197K ﹤0.01% 1698
2026
Q1 		$1.17M Sell
6,180
-11,178
-64% -$2.36M ﹤0.01% 1404
2025
Q4 		$3.45M Buy
17,358
+1,285
+8% +$260K 0.01% 812
2025
Q3 		$3.26M Buy
16,073
+14,303
+808% +$2.54M 0.01% 788
2025
Q2 		$312K Sell
1,770
-1,120
-39% -$169K ﹤0.01% 1997
2025
Q1 		$389K Buy
2,890
+166
+6% +$21.9K ﹤0.01% 1733
2024
Q4 		$344K Sell
2,724
-1,970
-42% -$293K ﹤0.01% 1798
2024
Q3 		$780K Sell
4,694
-1,433
-23% -$217K 0.01% 1220
2024
Q2 		$815K Sell
6,127
-2,376
-28% -$286K 0.01% 1163
2024
Q1 		$894K Buy
8,503
+892
+12% +$80.2K 0.01% 1052
2023
Q4 		$612K Buy
7,611
+930
+14% +$59K 0.01% 1178
2023
Q3 		$440K Buy
6,681
+3,223
+93% +$241K ﹤0.01% 1229
2023
Q2 		$281K Buy
3,458
+3,408
+6,816% +$243K ﹤0.01% 1477
2023
Q1 		$2.97K Sell
50
-188
-79% -$10.4K ﹤0.01% 2935
2022
Q4 		$4.89K Buy
+238
New +$11K ﹤0.01% 2603
2022
Q2 		– Sell
-12,449
Closed -$1.07M – 1617
2022
Q1 		$1.07M Sell
12,449
-14,346
-54% -$1.18M 0.02% 621
2021
Q4 		$2.19M Buy
26,795
+2,711
+11% +$198K 0.03% 421
2021
Q3 		$1.6M Buy
24,084
+1,561
+7% +$111K 0.04% 380
2021
Q2 		$1.51M Buy
+22,523
New +$1.4M 0.04% 379
2019
Q2 		– Sell
-28,604
Closed -$825K – 701
2019
Q1 		$825K Buy
28,604
+16,849
+143% +$416K 0.05% 304
2018
Q4 		$201K Buy
+11,755
New +$285K 0.01% 588
2015
Q1 		– Sell
-15,237
Closed -$772K – 73
2014
Q4 		$772K Buy
+15,237
New +$796K 0.6% 42

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

NewEdge Advisors's THC Position: Q2 2026 in Review

NewEdge Advisors reduced its Tenet Healthcare (THC) stake by 17% in Q2 2026, selling an estimated $197K and leaving 5,106 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

NewEdge Advisors first reported a position in THC in Q4 2014 and has held it in 22 quarters since. The position peaked at $3.45M in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • NewEdge Advisors held 5,106 shares of Tenet Healthcare worth $955K as of Q2 2026.
  • NewEdge Advisors sold 1,074 Tenet Healthcare shares in Q2 2026, an estimated $197K.
  • Tenet Healthcare made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1698 holding.
  • NewEdge Advisors first reported a position in Tenet Healthcare in Q4 2014 and has held it in 22 quarters since.
  • NewEdge Advisors's Tenet Healthcare position peaked at $3.45M in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.